Optimizing 3D Cell Culture Assays by Leveraging Kinetic Imaging and Endpoint Viability Analysis


Image- and luminescence-based viability quantification for scalable treatment-response characterization of 3D cell culture models


Key challenges in 3D screening—such as model quality, focus, and tracking treatment-response trajectories—limit the ability to support new approach methodology (NAM)-relevant drug discovery.

This application note details an optimized, high-throughput workflow for characterizing three-dimensional (3D) cell culture models (spheroids) by combining automated kinetic imaging with orthogonal endpoint viability analysis using the Agilent BioTek Cytation 9 cell imaging multimode reader.

Takeaways

Download the whitepaper to learn more.

  • Learn how kinetic imaging and endpoint viability measurements work together to provide a more complete understanding of 3D cell culture responses.
  • Explore strategies to evaluate spheroid formation, model quality, and treatment response in scalable high-throughput workflows.
  • See how quantitative measurements of spheroid size, morphology, uniformity, and compound-induced cytotoxicity can help optimize 3D assay development.
  • Discover how the Agilent BioTek Cytation 9 enables high-throughput 3D cell culture analysis by tracking spheroid quality, growth, and drug response over time from a single platform.

DOWNLOAD THIS APPLICATION NOTE

Become a member and enjoy exclusive benefits

Create an account now for exclusive benefits, personalized recommendations, and seamless order tracking. Elevate your lab experience today!